, et al. Cell Mol Immunol. 17:621–30 (2020).
5. Chen Y., et al., Biochem Biophys Res Commun.
525:135–40 (2020).
6. Hoffmann M., et al. Cell. 181:270–81.e8 (2020).
7. Lan J., et al. Nature. 581:215
, et al. Cell Mol Immunol. 17:621–30 (2020).
5. Chen Y., et al., Biochem Biophys Res Commun.
525:135–40 (2020).
6. Hoffmann M., et al. Cell. 181:270–81.e8 (2020).
7. Lan J., et al. Nature. 581:215
Mobile phase
See the gradient table:
Diluent: Acetonitrile and water (3:7)
St d d l ti
0 70 30
25 30 70
Standard solution
10 μg/mL of USP Letrozole RS in Diluent.
[Note—Dissolve
Thomas, D.A. et al., Immunity, 12, 621-632 (2000)
5. Heibein, J.A. et al., J. Immunol., 163, 4663-4693
(1999)
6. Smyth, M.J. et al., J. Immunol., 154, 6299-6305
(1995)
7. Pham, C.T.N., J. Biol. Chem.
Solution A (3:7)
Standard solution
1 mg/mL of USP Levofloxacin RS in Mobile phase
Sample solution
1 mg/mL of Levofloxacin in Mobile phase
Chromatographic system (See Chromatography 621, System Suitability
acetonitrile and water (3:2).
Make adjustments if necessary (see System Suitability under Chromatography 621).
Internal standard solution
Transfer about 40 mg of beclomethasone dipropionate to a 100-mL volumetric
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
myosin expressed in
the retina is a potential candidate for Bardet-Biedl
syndrome. Genomics, 79, 621-624 (2002).
2. Goldman, J.M. et al., Targeting the BCR-ABL
tyrosine kinase in chronic myeloid
myosin expressed in
the retina is a potential candidate for Bardet-Biedl
syndrome. Genomics, 79, 621-624 (2002).
2. Goldman, J.M. et al., Targeting the BCR-ABL
tyrosine kinase in chronic myeloid
myosin expressed in
the retina is a potential candidate for Bardet-Biedl
syndrome. Genomics, 79, 621-624 (2002).
2. Goldman, J.M. et al., Targeting the BCR-ABL
tyrosine kinase in chronic myeloid
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
acid)
Catalog Number S8313
References
1. Vorm, O. et al., 41st ASMS Conference
Proceedings, 621, (1994).
2. Sutton, C. W., et al., Electrophoresis, 16, 308-316
(1995).
3. http://www.ncbi.nlm.
340 and 341 and
serines 259 and 499 (activating), serine 43 (prevents
Ras:GTP binding), and serine 621(constitutive, required
for activity).6
Once active, Raf-1 phosphorylates and activates MAP
kinase
glycerol.
Molecular mass: ∼112 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 459–621 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for